Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
141,882
-
Shares change
-
-106,992
-
Total reported value, excl. options
-
$9,454,545
-
Value change
-
-$4,674,599
-
Put/Call ratio
-
244%
-
Number of buys
-
5
-
Number of sells
-
-11
-
Price
-
$66.63
Significant Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q3 2018
26 filings reported holding CURE - DIREXION SHS ETF TR - HEALTHCARE BUL as of Q3 2018.
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 141,882 shares
.
Largest 10 shareholders include CITADEL ADVISORS LLC (99,048 shares), BANQUE PICTET & CIE SA (10,120 shares), Traynor Capital Management, Inc. (7,396 shares), Virtu Financial LLC (6,947 shares), Capital Analysts, LLC (6,000 shares), MORGAN STANLEY (4,423 shares), SIMPLEX TRADING, LLC (3,646 shares), Integrated Wealth Concepts LLC (3,070 shares), UBS Group AG (1,124 shares), and Financial Architects, Inc (70 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.